Reproductive Health and Impact on Patients with End-Stage Liver Disease

Description

Panelists in this community conversation discuss complex cases involving reproductive health and pregnancy in persons with ESLD and liver transplantation. The panel includes a patient representative, a maternal fetal medicine specialist, an obstetrician, and a hepatologist. The session consists of individual presentations addressing current evidence-based guidance/guidelines around the topic followed by an interactive panel discussion of challenging clinical scenarios. The panel reviews current American Association for the Study of Liver Diseases (AASLD) guidance and the European Association for the Study of the Liver (EASL) guidelines addressing the approach to management of pregancy in the setting of ESLD post liver transplant.